# Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

> **NCT04119167** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Polyneuropathy
- Diabetic Nephropathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04119167
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119167, "Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04119167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*